Wendy has built her patient advocacy career in many rare disease communities and oncology. Wendy Erler is the VicePresident of Patient Experience, STAR, and Advocacy at AstraZeneca in Alexion’s rare disease, where she is responsible for leading the enterprise innovation model to gather and incorporate patient insights throughout the drug development and commercialization processes. She leads the Global PatientAdvocacy function and has responsibility for the rare disease patient advocacy team. Previously, Ms. Erler was on the executive leadership team at Wave LifeSciences where she led Patient Advocacy and Commercial. Wendy graduated from Miami University and earned her MBA from St. Joseph’s University.